1. Introduction
1.1. Study Objective
1.2. Scope of the report
1.3. Market Taxonomy
1.4. Study Assumptions and Abbreviations
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. SPSS Approach
2.4. Data Triangulation
2.5. Client-specific Requirements and Tailored Solutions
3. Executive Summary
3.1. Competitive Landscape
3.2. Competitive Intelligence
3.3. Outcome: Actionable Insights
4. Global Industry Overview
4.1. Market Overview
4.2. Global Demand Growth of Plant-based API (2020-2036)
4.3. Demand Share by Region
4.4. Regional Market Insights: Plant-Based API
4.5. Top Import & Export Markets
4.6. Comparative Overview of Plant-based and Synthetic API
4.7. Comparative Assessment of Plant-based Molecules
4.8. Application-wise Insights: Adoption, Trends, and Future Potential
4.9. Competitive Landscape
4.10. Major Buyers Of API: Purchasing Trends and Strategies
4.11. Regional Synopsis
4.12. Industry Supply Chain Analysis
4.13. DROT
4.14. Regulatory Framework
4.15. Ongoing Technological Advancements
4.16. Pice Benchmarking
4.17. Patents Filed in The Industry
4.18. Root Cause Analysis (RCA) for the Market
4.19. Pestle Analysis
4.20. Porter Five Forces Analysis
4.21. Industry Risk Assessment
5. Global Outlook and Projections
5.1. Global Overview
5.1.1. Market Value (USD Million), Volume (Thousand/Gram) Current and Future Projections, 2020-2036
5.1.2. Increment $ Opportunity Assessment, 2020-2036
5.1.3. Year-on-Year Growth Forecast (%)
5.2. Global Segmentation (USD Million), 2020-2036, By
5.2.1. Molecule Type, Value (USD Million), Volume (Thousand/Gram)
5.2.1.1. Alkaloids
5.2.1.2. Phenolic Acids
5.2.1.3. Terpenoids
5.2.1.4. Lignin & Stilbenes
5.2.1.5. Anthocyanin
5.2.1.6. Flavonoids
5.2.1.7. Others
5.2.2. Form Type, Value (USD Million)
5.2.2.1. Liquid
5.2.2.2. Powder
5.2.2.3. Granules
5.2.3. Application, Value (USD Million)
5.2.3.1. Oncology
5.2.3.2. Cardiovascular
5.2.3.3. Anti-inflammatory
5.2.3.4. Pain Management
5.2.3.5. Respiratory Disorders
5.2.3.6. Diabetes
5.2.3.7. Anti-viral / Anti-bacterial / Anti-fungal
5.2.3.8. Others
5.2.4. End-User, Value (USD Million)
5.2.4.1. Pharmaceuticals
5.2.4.2. Nutraceuticals
5.2.4.3. Herbal Based Industries
5.2.4.4. Others
5.2.5. Regional Synopsis (USD Million) 2020-2036
5.2.5.1. North America, Value (USD Million), Volume (Thousand/Gram)
5.2.5.2. Europe, Value (USD Million), Volume (Thousand/Gram)
5.2.5.3. Asia Pacific, Value (USD Million), Volume (Thousand/Gram)
5.2.5.4. Latin America, Value (USD Million), Volume (Thousand/Gram)
5.2.5.5. Middle East and Africa, Value (USD Million), Volume (Thousand/Gram)
6. North America Market
6.1. Overview
6.1.1. Market Value (USD Million), Current and Future Projections, 2020-2036
6.1.2. Increment $ Opportunity Assessment, 2020-2036
6.1.3. Year-on-Year Growth Forecast (%)
6.2. Segmentation (USD Million), 2020-2036, By
6.2.1. Molecule Type, Value (USD Million), Volume (Thousand/Gram)
6.2.1.1. Alkaloids
6.2.1.2. Phenolic Acids
6.2.1.3. Terpenoids
6.2.1.4. Lignin & Stilbenes
6.2.1.5. Anthocyanin
6.2.1.6. Flavonoids
6.2.1.7. Others
6.2.2. Form Type, Value (USD Million)
6.2.2.1. Liquid
6.2.2.2. Powder
6.2.2.3. Granules
6.2.3. Application, Value (USD Million)
6.2.3.1. Oncology
6.2.3.2. Cardiovascular
6.2.3.3. Anti-inflammatory
6.2.3.4. Pain Management
6.2.3.5. Respiratory Disorders
6.2.3.6. Diabetes
6.2.3.7. Anti-viral / Anti-bacterial / Anti-fungal
6.2.3.8. Others
6.2.4. End-User, Value (USD Million)
6.2.4.1. Pharmaceuticals
6.2.4.2. Nutraceuticals
6.2.4.3. Herbal Based Industries
6.2.4.4. Others
6.2.5. Country Level Analysis, Value (USD Million), Volume (Thousand/Gram)
6.2.5.1. US
6.2.5.2. Canada
7. Europe Market
7.1. Overview
7.1.1. Market Value (USD Million), Current and Future Projections, 2020-2036
7.1.2. Increment $ Opportunity Assessment, 2020-2036
7.1.3. Year-on-Year Growth Forecast (%)
7.2. Segmentation (USD Million), 2020-2036, By
7.2.1. Molecule Type, Value (USD Million), Volume (Thousand/Gram)
7.2.1.1. Alkaloids
7.2.1.2. Phenolic Acids
7.2.1.3. Terpenoids
7.2.1.4. Lignin & Stilbenes
7.2.1.5. Anthocyanin
7.2.1.6. Flavonoids
7.2.1.7. Others
7.2.2. Form Type, Value (USD Million)
7.2.2.1. Liquid
7.2.2.2. Powder
7.2.2.3. Granules
7.2.3. Application, Value (USD Million)
7.2.3.1. Oncology
7.2.3.2. Cardiovascular
7.2.3.3. Anti-inflammatory
7.2.3.4. Pain Management
7.2.3.5. Respiratory Disorders
7.2.3.6. Diabetes
7.2.3.7. Anti-viral / Anti-bacterial / Anti-fungal
7.2.3.8. Others
7.2.4. End-User, Value (USD Million)
7.2.4.1. Pharmaceuticals
7.2.4.2. Nutraceuticals
7.2.4.3. Herbal Based Industries
7.2.4.4. Others
7.2.5. Country Level Analysis, Value (USD Million), Volume (Thousand/Gram)
7.2.5.1. UK
7.2.5.2. Germany
7.2.5.3. France
7.2.5.4. Italy
7.2.5.5. Spain
7.2.5.6. Russia
7.2.5.7. Netherlands
7.2.5.8. Switzerland
7.2.5.9. Poland
7.2.5.10. Belgium
7.2.5.11. Rest of Europe
8. Asia-Pacific Market
8.1. Overview
8.1.1. Market Value (USD Million), Current and Future Projections, 2020-2036
8.1.2. Increment $ Opportunity Assessment, 2020-2036
8.1.3. Year-on-Year Growth Forecast (%)
8.2. Segmentation (USD Million), 2020-2036, By
8.2.1. Molecule Type, Value (USD Million), Volume (Thousand/Gram)
8.2.1.1. Alkaloids
8.2.1.2. Phenolic Acids
8.2.1.3. Terpenoids
8.2.1.4. Lignin & Stilbenes
8.2.1.5. Anthocyanin
8.2.1.6. Flavonoids
8.2.1.7. Others
8.2.2. Form Type, Value (USD Million)
8.2.2.1. Liquid
8.2.2.2. Powder
8.2.2.3. Granules
8.2.3. Application, Value (USD Million)
8.2.3.1. Oncology
8.2.3.2. Cardiovascular
8.2.3.3. Anti-inflammatory
8.2.3.4. Pain Management
8.2.3.5. Respiratory Disorders
8.2.3.6. Diabetes
8.2.3.7. Anti-viral / Anti-bacterial / Anti-fungal
8.2.3.8. Others
8.2.4. End-User, Value (USD Million)
8.2.4.1. Pharmaceuticals
8.2.4.2. Nutraceuticals
8.2.4.3. Herbal Based Industries
8.2.4.4. Others
8.2.5. Country Level Analysis, Value (USD Million), Volume (Thousand/Gram)
8.2.5.1. China
8.2.5.2. Japan
8.2.5.3. India
8.2.5.4. South Korea
8.2.5.5. Australia
8.2.5.6. Indonesia
8.2.5.7. Taiwan
8.2.5.8. Thailand
8.2.5.9. Singapore
8.2.5.10. Philippines
8.2.5.11. Vietnam
8.2.5.12. New Zealand
8.2.5.13. Malaysia
8.2.5.14. Rest of Asia Pacific
9. Latin America Market
9.1. Overview
9.1.1. Market Value (USD Million), Current and Future Projections, 2020-2036
9.1.2. Increment $ Opportunity Assessment, 2020-2036
9.1.3. Year-on-Year Growth Forecast (%)
9.2. Segmentation (USD Million), 2020-2036, By
9.2.1. Molecule Type, Value (USD Million), Volume (Thousand/Gram)
9.2.1.1. Alkaloids
9.2.1.2. Phenolic Acids
9.2.1.3. Terpenoids
9.2.1.4. Lignin & Stilbenes
9.2.1.5. Anthocyanin
9.2.1.6. Flavonoids
9.2.1.7. Others
9.2.2. Form Type, Value (USD Million)
9.2.2.1. Liquid
9.2.2.2. Powder
9.2.2.3. Granules
9.2.3. Application, Value (USD Million)
9.2.3.1. Oncology
9.2.3.2. Cardiovascular
9.2.3.3. Anti-inflammatory
9.2.3.4. Pain Management
9.2.3.5. Respiratory Disorders
9.2.3.6. Diabetes
9.2.3.7. Anti-viral / Anti-bacterial / Anti-fungal
9.2.3.8. Others
9.2.4. End-User, Value (USD Million)
9.2.4.1. Pharmaceuticals
9.2.4.2. Nutraceuticals
9.2.4.3. Herbal Based Industries
9.2.4.4. Others
9.2.5. Country Level Analysis, Value (USD Million), Volume (Thousand/Gram)
9.2.5.1. Brazil
9.2.5.2. Mexico
9.2.5.3. Argentina
9.2.5.4. Rest of Latin America
10. Middle East & Africa Market
10.1. Overview
10.1.1. Market Value (USD Million), Current and Future Projections, 2020-2036
10.1.2. Increment $ Opportunity Assessment, 2020-2036
10.1.3. Year-on-Year Growth Forecast (%)
10.2. Segmentation (USD Million), 2020-2036, By
10.2.1. Molecule Type, Value (USD Million), Volume (Thousand/Gram)
10.2.1.1. Alkaloids
10.2.1.2. Phenolic Acids
10.2.1.3. Terpenoids
10.2.1.4. Lignin & Stilbenes
10.2.1.5. Anthocyanin
10.2.1.6. Flavonoids
10.2.1.7. Others
10.2.2. Form Type, Value (USD Million)
10.2.2.1. Liquid
10.2.2.2. Powder
10.2.2.3. Granules
10.2.3. Application, Value (USD Million)
10.2.3.1. Oncology
10.2.3.2. Cardiovascular
10.2.3.3. Anti-inflammatory
10.2.3.4. Pain Management
10.2.3.5. Respiratory Disorders
10.2.3.6. Diabetes
10.2.3.7. Anti-viral / Anti-bacterial / Anti-fungal
10.2.3.8. Others
10.2.4. End-User, Value (USD Million)
10.2.4.1. Pharmaceuticals
10.2.4.2. Nutraceuticals
10.2.4.3. Herbal Based Industries
10.2.4.4. Others
10.2.5. Country Level Analysis, Value (USD Million), Volume (Thousand/Gram)
10.2.5.1. Saudi Arabia
10.2.5.2. UAE
10.2.5.3. Israel
10.2.5.4. Qatar
10.2.5.5. Kuwait
10.2.5.6. Oman
10.2.5.7. South Africa
10.2.5.8. Rest of Middle East & Africa
11. About the Analyst
11.1. Global Clientele
11.2. Clients Served Across World
11.3. Legal Disclaimer
